Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases 10 (2023) 1367–1401, (S2352304222000472), (10.1016/j.gendis.2022.02.007)]

Uttpal Anand; Abhijit Dey; Arvind K. Singh Chandel; Rupa Sanyal; Amarnath Mishra; Devendra Kumar Pandey; Valentina De Falco; Arun Upadhyay; Ramesh Kandimalla; Anupama Chaudhary; Jaspreet Kaur Dhanjal; Saikat Dewanjee; Jayalakshmi Vallamkondu; José M. Pérez de la Lastra

doi:10.1016/j.gendis.2024.101211

Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases 10 (2023) 1367–1401, (S2352304222000472), (10.1016/j.gendis.2022.02.007)]

Uttpal Anand
, Abhijit Dey
, Arvind K. Singh Chandel
, Rupa Sanyal
, Amarnath Mishra
, Devendra Kumar Pandey
, Valentina De Falco
, Arun Upadhyay
, Ramesh Kandimalla
, Anupama Chaudhary
, Jaspreet Kaur Dhanjal
, Saikat Dewanjee
, Jayalakshmi Vallamkondu
, José M. Pérez de la Lastra

Ben-Gurion University of the Negev
Presidency College India
The University of Tokyo
West Bengal State University
Amity University, Noida
Lovely Professional University
University of Naples Federico II
Central University of Rajasthan
CSIR - Indian Institute of Chemical Technology
Kakatiya Medical College
Orinin-BioSystems
Indraprastha Institute of Information Technology Delhi
Jadavpur University
National Institute of Technology Warangal
Instituto de Productos Naturales y Agrobiología (IPNA-CSIC)

Research output: Contribution to journal › Comment/debate

Abstract

In the published article, there was an error in the affiliation information about the first author Uttpal Anand [a]. Instead of “Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel”, it should be “CytoGene Research & Development LLP, K-51, UPSIDA Industrial Area, Kursi Road (Lucknow), Dist.–Barabanki, 225001, Uttar Pradesh, India”. The authors would like to apologize for any inconvenience caused and state that this does not change the scientific conclusions of the article in any way.

Original language	English
Article number	101211
Journal	Genes & Diseases
Volume	11
Issue number	4
DOIs	https://doi.org/10.1016/j.gendis.2024.101211
Publication status	Published - Jul 2024
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.gendis.2024.101211

Fingerprint

Dive into the research topics of 'Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases 10 (2023) 1367–1401, (S2352304222000472), (10.1016/j.gendis.2022.02.007)]'. Together they form a unique fingerprint.

Cite this

Anand, U., Dey, A., Singh Chandel, A. K., Sanyal, R., Mishra, A., Pandey, D. K., De Falco, V., Upadhyay, A., Kandimalla, R., Chaudhary, A., Dhanjal, J. K., Dewanjee, S., Vallamkondu, J., & Pérez de la Lastra, J. M. (2024). Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases 10 (2023) 1367–1401, (S2352304222000472), (10.1016/j.gendis.2022.02.007)]. Genes & Diseases, 11(4), Article 101211. https://doi.org/10.1016/j.gendis.2024.101211

@article{e40a7f70b73d4b2ba83b6286d81c9336,

title = "Corrigendum to {\textquoteleft}Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics{\textquoteright} [Genes \& Diseases 10 (2023) 1367–1401, (S2352304222000472), (10.1016/j.gendis.2022.02.007)]",

abstract = "In the published article, there was an error in the affiliation information about the first author Uttpal Anand [a]. Instead of “Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel”, it should be “CytoGene Research \& Development LLP, K-51, UPSIDA Industrial Area, Kursi Road (Lucknow), Dist.–Barabanki, 225001, Uttar Pradesh, India”. The authors would like to apologize for any inconvenience caused and state that this does not change the scientific conclusions of the article in any way.",

author = "Uttpal Anand and Abhijit Dey and \{Singh Chandel\}, \{Arvind K.\} and Rupa Sanyal and Amarnath Mishra and Pandey, \{Devendra Kumar\} and \{De Falco\}, Valentina and Arun Upadhyay and Ramesh Kandimalla and Anupama Chaudhary and Dhanjal, \{Jaspreet Kaur\} and Saikat Dewanjee and Jayalakshmi Vallamkondu and \{P{\'e}rez de la Lastra\}, \{Jos{\'e} M.\}",

note = "Publisher Copyright: {\textcopyright} 2024 Chongqing Medical University",

year = "2024",

month = jul,

doi = "10.1016/j.gendis.2024.101211",

language = "English",

volume = "11",

journal = "Genes \& Diseases",

issn = "2352-4820",

number = "4",

}

Anand, U, Dey, A, Singh Chandel, AK, Sanyal, R, Mishra, A, Pandey, DK, De Falco, V, Upadhyay, A, Kandimalla, R, Chaudhary, A, Dhanjal, JK, Dewanjee, S, Vallamkondu, J & Pérez de la Lastra, JM 2024, 'Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases 10 (2023) 1367–1401, (S2352304222000472), (10.1016/j.gendis.2022.02.007)]', Genes & Diseases, vol. 11, no. 4, 101211. https://doi.org/10.1016/j.gendis.2024.101211

Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases 10 (2023) 1367–1401, (S2352304222000472), (10.1016/j.gendis.2022.02.007)]. / Anand, Uttpal; Dey, Abhijit; Singh Chandel, Arvind K. et al.
In: Genes & Diseases, Vol. 11, No. 4, 101211, 07.2024.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Corrigendum to ‘Cancer chemotherapy and beyond

T2 - Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases 10 (2023) 1367–1401, (S2352304222000472), (10.1016/j.gendis.2022.02.007)]

AU - Anand, Uttpal

AU - Dey, Abhijit

AU - Singh Chandel, Arvind K.

AU - Sanyal, Rupa

AU - Mishra, Amarnath

AU - Pandey, Devendra Kumar

AU - De Falco, Valentina

AU - Upadhyay, Arun

AU - Kandimalla, Ramesh

AU - Chaudhary, Anupama

AU - Dhanjal, Jaspreet Kaur

AU - Dewanjee, Saikat

AU - Vallamkondu, Jayalakshmi

AU - Pérez de la Lastra, José M.

PY - 2024/7

Y1 - 2024/7

N2 - In the published article, there was an error in the affiliation information about the first author Uttpal Anand [a]. Instead of “Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel”, it should be “CytoGene Research & Development LLP, K-51, UPSIDA Industrial Area, Kursi Road (Lucknow), Dist.–Barabanki, 225001, Uttar Pradesh, India”. The authors would like to apologize for any inconvenience caused and state that this does not change the scientific conclusions of the article in any way.

AB - In the published article, there was an error in the affiliation information about the first author Uttpal Anand [a]. Instead of “Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel”, it should be “CytoGene Research & Development LLP, K-51, UPSIDA Industrial Area, Kursi Road (Lucknow), Dist.–Barabanki, 225001, Uttar Pradesh, India”. The authors would like to apologize for any inconvenience caused and state that this does not change the scientific conclusions of the article in any way.

UR - https://www.scopus.com/pages/publications/85189036657

U2 - 10.1016/j.gendis.2024.101211

DO - 10.1016/j.gendis.2024.101211

M3 - Comment/debate

AN - SCOPUS:85189036657

SN - 2352-4820

VL - 11

JO - Genes & Diseases

JF - Genes & Diseases

IS - 4

M1 - 101211

ER -

Anand U, Dey A, Singh Chandel AK, Sanyal R, Mishra A, Pandey DK et al. Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases 10 (2023) 1367–1401, (S2352304222000472), (10.1016/j.gendis.2022.02.007)]. Genes & Diseases. 2024 Jul;11(4):101211. doi: 10.1016/j.gendis.2024.101211

Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases 10 (2023) 1367–1401, (S2352304222000472), (10.1016/j.gendis.2022.02.007)]

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this